Comparison of safety and efficacy of asthma treatments; fluticasone furoate/ vilanterol trifenatate and inhaled corticosteroid combination therapy, in patients with Asian ancestry. - Trial 2015-004871-59
Access comprehensive clinical trial information for 2015-004871-59 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. History of Life-threatening asthma: Defined for this protocol as an asthma episode that required intubation and/or was associated with hypercapnea, respiratory arrest or hypoxic seizures within the last 10 years.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004871-59
Non-Device Trial